Results 111 to 120 of about 21,804,485 (185)

Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum

open access: yesMaterials Today Bio
Malaria remains a significant global health burden, particularly in low- and middle-income countries. Artemisinin-based combination therapies (ACTs) are the current gold standard for treating Plasmodium falciparum infections, combining a fast-acting ...
Qonita Kurnia Anjani   +13 more
doaj   +1 more source

Oral drug absorption and the biopharmaceutics classification system

open access: yes, 2007
Bioavailability (BA) and bioequivalence (BE) play a central role in pharmaceutical product development and BE studies are presently being conducted for New Drug Application (NDAs) of new compounds, in supplementary NDAsfor new medical indications and ...
Lennernäs, Hans,   +3 more
core  

Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug–Polymer Interactions to in vivo Performance

open access: yesDrug Design, Development and Therapy
Sucilawaty Ridwan,1,2 Rimadani Pratiwi,3 Suci Zulaikha Hildayani,4 Arif Budiman11Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia; 2Department of Pharmacy, Faculty of ...
Ridwan S   +3 more
doaj  

[In vitro permeability studies as substitute for in vivo studies - which requirements have to be met?] [Article in German]

open access: yesALTEX: Alternatives to Animal Experimentation, 2001
In order to reduce costs and shorten time-to-market, the permeability of drug substances can be characterised by in vitro techniques including the use of cell and tissue models. It is required to apply appropriate quality standards similar to those used
Eleonore Haltner   +3 more
doaj  

Biopharmaceutics Classification System (BCS) An overview

open access: yesInternational Journal of Pharmaceutical Sciences Review and Research
Dr Pooja Agrawal   +5 more
openaire   +1 more source

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. [PDF]

open access: yesPharmaceutics
McAllister M   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy